Indian Institute of Technology Roorkee (IIT Roorkee) scientists have developed an improved orthopedic implant technology for sustained drug release. Currently, the technology is with the company, Biotech Consortium India Limited (BCIL) for transfer, for the commercialization of the technology.
UK-based BenevolentAI raised one of the largest fundings in AI pharmaceutical field. The company is significantly disrupting the pharma industry which spends $180 billion in a year on R&D.
Genprex raised $6.4 million in IPO at a share price of $5.
Unlike most of the commercial blockbuster lung cancer immunotherapies, its unique lead candidate, Oncoprex® targets advanced lung cancer treatment.
KEY POINTS Academic researchers have designed a smartphone-controlled “smart” bandage. Unlike the traditional bandages, no redressing of the wound is ...